These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Genetics and the potential for predictive tests in adverse drug reactions. Pirmohamed M Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851 [TBL] [Abstract][Full Text] [Related]
14. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Amstutz U; Shear NH; Rieder MJ; Hwang S; Fung V; Nakamura H; Connolly MB; Ito S; Carleton BC; Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466 [TBL] [Abstract][Full Text] [Related]
15. [Hyperkeratotic vegetating form of mycosis fungoides. A case report]. Andreev VC; Dogramadijev D Hautarzt; 1978 Apr; 29(4):219-21. PubMed ID: 148438 [TBL] [Abstract][Full Text] [Related]
17. Keratoderma-like T cell dyscrasia: A report of 13 cases and its distinction from mycosis fungoides palmaris et plantaris. Magro CM; Nguyen GH Indian J Dermatol Venereol Leprol; 2016; 82(4):395-403. PubMed ID: 27279297 [TBL] [Abstract][Full Text] [Related]
18. [Clinical, histological and immunohistochemical study of the early diagnosis of mycosis fungoides]. Goos M; Eckstein M; Biskup K Z Hautkr; 1983 Mar; 58(6):373-84. PubMed ID: 6845804 [No Abstract] [Full Text] [Related]
19. A case of CD56+ mycosis fungoides. Klekotka PA; Faulkner-Jones B; Heffernan MP Arch Dermatol; 2006 Oct; 142(10):1370-2. PubMed ID: 17043207 [No Abstract] [Full Text] [Related]